(Q37850156)

24 August 2017

title

Effects of coadministration of natural polyphenols with doxycycline or calcium modulators on acute Chlamydia pneumoniae infection in vitro (English)

1 reference

Chlamydia pneumoniae infection

24 August 2017

1 reference

1 reference

1 reference

Chlamydia pneumoniae

1 reference

5

Maija Leinonen

1 reference

24 August 2017

3

Pekka Saikku

1 reference

24 August 2017

Olli P Salin

1

1 reference

24 August 2017

Leena L Pohjala

series ordinal

2

1 reference

24 August 2017

Heikki J Vuorela

series ordinal

4

1 reference

24 August 2017

Pia M Vuorela

series ordinal

6

1 reference

24 August 2017

publication date

21 September 2011

1 reference

The Journal of Antibiotics

24 August 2017

published in

1 reference

24 August 2017

volume

64

1 reference

24 August 2017

issue

11

1 reference

24 August 2017

page(s)

747-752

1 reference

https://scigraph.springernature.com/pub.10.1038/ja.2011.79

24 August 2017

exact match

0 references

cites work

Demonstration of Chlamydia pneumoniae in atherosclerotic arteries from various vascular regions

1 reference

https://api.crossref.org/works/10.1038%2FJA.2011.79

Chlamydia pneumoniae--induced macrophage foam cell formation is mediated by Toll-like receptor 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2011.79

Chlamydia pneumoniae infection accelerates hyperlipidemia induced atherosclerotic lesion development in C57BL/6J mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2011.79

Increased aortic intima-media thickness in 11-year-old healthy children with persistent Chlamydia pneumoniae seropositivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2011.79

How antibiotics kill bacteria: from targets to networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2011.79

Combination antibiotics as a treatment for chronic Chlamydia-induced reactive arthritis: a double-blind, placebo-controlled, prospective trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2011.79

Effect of prolonged treatment with azithromycin, clarithromycin, or levofloxacin on Chlamydia pneumoniae in a continuous-infection Model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2011.79

Infections caused by Chlamydia pneumoniae strain TWAR

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2011.79

First-choice antibiotics at subinhibitory concentrations induce persistence of Chlamydia pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2011.79

Divergent modulation of Chlamydia pneumoniae infection cycle in human monocytic and endothelial cells by iron, tryptophan availability and interferon gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2011.79

Chlamydia pneumoniae infection in circulating human monocytes is refractory to antibiotic treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2011.79

Potential role of the cardiovascular non-antibiotic (helper compound) amlodipine in the treatment of microbial infections: scope and hope for the future

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2011.79

Macrophage L-type Ca2+ channel antagonists alter Chlamydia pneumoniae MOMP and HSP-60 mRNA gene expression, and improve antibiotic susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2011.79

Inhibitory effect of dietary phenolic compounds on Chlamydia pneumoniae in cell cultures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2011.79

In vivo treatment of acute Chlamydia pneumoniae infection with the flavonoids quercetin and luteolin and an alkyl gallate, octyl gallate, in a mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2011.79

Cardiovascular ion channels as a molecular target of flavonoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2011.79

Effects of simple aromatic compounds and flavonoids on Ca2+ fluxes in rat pituitary GH(4)C(1) cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2011.79

Antimicrobial activity of flavonoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2011.79

Prospects for plant-derived antibacterials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2011.79

Activity and interactions of antibiotic and phytochemical combinations against Pseudomonas aeruginosa in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2011.79

Inhibition of Listeria monocytogenes infection by neurological drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2011.79

Interaction between antibiotics and non-conventional antibiotics on bacteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2011.79

Microarray analysis of a Chlamydia pneumoniae-infected human epithelial cell line by use of gene ontology hierarchy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2011.79

Inhibitory effect of the natural product betulin and its derivatives against the intracellular bacterium Chlamydia pneumoniae.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2011.79

Design and synthesis of 2-arylbenzimidazoles and evaluation of their inhibitory effect against Chlamydia pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2011.79

An in-vitro investigation of synergy and antagonism between antimicrobials against Chlamydia trachomatis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2011.79

Chlamydia pneumoniae (TWAR).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2011.79

inferred from DOI database lookup

7 January 2021

based on heuristic

Effective macrophage redox defense against Chlamydia pneumoniae depends on L-type Ca2+ channel activation

1 reference

https://api.crossref.org/works/10.1038%2FJA.2011.79

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/JA.2011.79

1 reference

Dimensions Publication ID

24 August 2017

1000272233

0 references

1 reference